Skip to main navigation Skip to search Skip to main content

RAMPs as drug targets

  • Patrick M Sexton
  • , David R Poyner
  • , John Simms
  • , Arthur Christopoulos
  • , Debbie L Hay

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    Abstract

    The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.

    Original languageEnglish
    Title of host publicationRAMPS
    EditorsWilliam S. Spielman, Narayanan Parameswaran
    PublisherSpringer
    Pages61-74
    Number of pages14
    ISBN (Electronic)9781461423638
    DOIs
    Publication statusPublished - 2012

    Publication series

    NameAdvances in Experimental Medicine and Biology
    PublisherSpringer
    Volume744

    Keywords

    • Receptor Activity-Modifying Proteins
    • Receptors, G-Protein-Coupled
    • Signal Transduction
    • Journal Article
    • Review

    Fingerprint

    Dive into the research topics of 'RAMPs as drug targets'. Together they form a unique fingerprint.

    Cite this